Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer

OBJECTIVES: Immune checkpoint inhibitors (ICIs) have modest activity in ovarian cancer (OC), yet little is known about their effects on subsequent treatment. Preclinical studies suggest immunotherapy may enhance response to chemotherapy. We sought to evaluate the impact of ICIs on subsequent therapi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gynecol Oncol
Main Authors: Liu, Ying L., Zhou, Qin, Iasonos, Alexia, Emengo, Vivian N., Friedman, Claire, Konner, Jason A., O’Cearbhaill, Roisin E., Aghajanian, Carol, Zamarin, Dmitriy
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6788969/
https://ncbi.nlm.nih.gov/pubmed/31421916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2019.08.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados